JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: BGP-15 is a potent PARP inhibitor that can protect against heart failure and atrial fibrillation in mice. BGP-15 (200 uM) prevents the imatinib mesylate-induced oxidative damages, attenuates the depletion of high-energy phosphates, alters the signaling effect of imatinib mesylate by preventing p38 MAP kinase and JNK activation, and induced the phosphorylation of Akt and GSK-3beta. In-vivo study indicated that BGP-15 improved cardiac function and reduced arrhythmic episodes in two HF and AF mouse models. In these models, BGP-15 was associated with increased phosphorylation of IGF1R.
References: Am J Pathol. 2016; 186:3246-3260; Sci Transl Med. 2016; 8(350):350ra103; Nat Commun. 2014; 5:5705.
Related CAS #: 66611-37-8 (HCl) 66611-38-9 (free base)
Chemical Name: N-(2-hydroxy-3-(piperidin-1-yl)propoxy)nicotinimidamide
SMILES Code: N=C(NOCC(O)CN1CCCCC1)C2=CN=CC=C2
BGP15; BGP-15; BGP 15; BGP15 hydrochloride; BGP15 HCl; N-(2-hydroxy-3-(piperidin-1-yl)propoxy)nicotinimidamide dihydrochloride
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!